Pindolol

CAS No. 13523-86-9

Pindolol( DL-Pindolol )

Catalog No. M11429 CAS No. 13523-86-9

Pindolol is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial agonist / antagonist (Ki=33nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pindolol
  • Note
    Research use only, not for human use.
  • Brief Description
    Pindolol is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial agonist / antagonist (Ki=33nM).
  • Description
    Pindolol is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial agonist / antagonist (Ki=33nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DL-Pindolol
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT1A| β-adrenergic receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    13523-86-9
  • Formula Weight
    248.32
  • Molecular Formula
    C14H20N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
  • Chemical Name
    1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Joseph SS, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):496-503.
molnova catalog
related products
  • Peptide 401

    Peptide 401 is an antimicrobial peptide (AMP) derived from the venom of bees and wasps. Peptide 401 induces mast cell degranulation, activating histamine release from peritoneal mast cells. Additionally, peptide 401 exhibits some anti-inflammatory activity, decreasing paw edema in animal models.

  • VA-012

    VA-012 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM) that exhibits dose-dependent potentiation of 5-HT efficacy with EC50 of 16 nM.

  • Pimavanserin

    Pimavanserin(ACP-103) is a potent and selective 5-HT2A receptor inverse agonist with mean pIC50 of with 8.7 in the cell-based functional assay.